Clinical Trial Update: Community Based Trial for AMEVIVE® [Phase 4]

View source ↗

Summary

Phase 4 community-based trial of AMEVIVE (efalizumab) for moderate to severe chronic plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Amevive (alefacept)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Moderate to Severe Chronic Plaque Psoriasis | Phase 4 | Status: COMPLETED